Dashboard
Manage Tickers

RXST RxSight, Inc.

Nasdaq rxsight.com


$ 9.94 $ 0.00 (0 %)    

Thursday, 06-Nov-2025 07:59:40 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 624.38 $ 0.00 (0 %)
DIA $ 473.40 $ 0.00 (0 %)
SPY $ 678.83 $ 0.00 (0 %)
TLT $ 89.13 $ 0.00 (0 %)
GLD $ 368.50 $ 0.00 (0 %)
$ 8.34
$ 8.88
$ 9.57 x 100
$ 9.95 x 7
-- - --
$ 6.32 - $ 55.57
1,159,384
na
342.91M
$ 1.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 02-25-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-05-2024 06-30-2024 10-Q
7 05-06-2024 03-31-2024 10-Q
8 02-28-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-07-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-06-2023 12-31-2022 10-K
13 11-07-2022 09-30-2022 10-Q
14 08-08-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-08-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 09-09-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
11/06/2025 12:05:55

needham-maintains-buy-on-rxsight-raises-price-target-to-12
Needham Maintains Buy on RxSight, Raises P...
11/06/2025 10:12:36

Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $11 to $12.

rxsight-raises-fy2025-sales-guidance-from-120000m-130000m-to-125000m-130000m-vs-125489m-est
RxSight Raises FY2025 Sales Guidance from ...
11/05/2025 21:20:17

RxSight (NASDAQ:RXST) raises FY2025 sales outlook from $120.000 million-$130.000 million to $125.000 million-$130.000 million v...

rxsight-q3-adj-eps-004-beats-038-estimate-sales-30300m-beat-25278m-estimate
RxSight Q3 Adj. EPS $(0.04) Beats $(0.38) ...
11/05/2025 21:19:44

RxSight (NASDAQ:RXST) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.38) by 89...

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

ubs-maintains-neutral-on-rxsight-lowers-price-target-to-8
UBS Maintains Neutral on RxSight, Lowers P...
08/08/2025 18:44:42

UBS analyst Danielle Antalffy maintains RxSight (NASDAQ:RXST) with a Neutral and lowers the price target from $16 to $8.

stifel-maintains-hold-on-rxsight-lowers-price-target-to-8
Stifel Maintains Hold on RxSight, Lowers P...
08/08/2025 15:39:15

Stifel analyst Tom Stephan maintains RxSight (NASDAQ:RXST) with a Hold and lowers the price target from $9 to $8.

needham-maintains-buy-on-rxsight-lowers-price-target-to-11
Needham Maintains Buy on RxSight, Lowers P...
08/08/2025 11:20:50

Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $22 to $11.

rxsight-affirms-fy2025-sales-guidance-of-12000m-13000m-vs-16758m-est
RxSight Affirms FY2025 Sales Guidance of $...
08/07/2025 20:06:29

RxSight (NASDAQ:RXST) affirms FY2025 sales outlook from $120.00 million-$130.00 million to $120.00 million-$130.00 million vs $...

rxsight-q2-adj-eps-008-beats-017-estimate-sales-3364m-miss-3977m-estimate
RxSight Q2 Adj. EPS $(0.08) Beats $(0.17) ...
08/07/2025 20:06:03

RxSight (NASDAQ:RXST) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.17) by 52...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

morgan-stanley-downgrades-rxsight-to-equal-weight-lowers-price-target-to-9
Morgan Stanley Downgrades RxSight to Equal...
07/15/2025 13:02:17

Morgan Stanley analyst Patrick Wood downgrades RxSight (NASDAQ:RXST) from Overweight to Equal-Weight and lowers the price ta...

top-3-health-care-stocks-that-could-blast-off-in-july
Top 3 Health Care Stocks That Could Blast ...
07/14/2025 11:07:48

jefferies-downgrades-rxsight-to-hold-lowers-price-target-to-9
Jefferies Downgrades RxSight to Hold, Lowe...
07/10/2025 11:48:24

Jefferies analyst Young Li downgrades RxSight (NASDAQ:RXST) from Buy to Hold and lowers the price target from $24 to $9.

crude-oil-moves-higher-rxsight-shares-plunge
Crude Oil Moves Higher; RxSight Shares Plunge
07/09/2025 17:33:45

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/09/2025 17:06:52

alphabet-to-rally-around-26-here-are-10-top-analyst-forecasts-for-wednesday
Alphabet To Rally Around 26%? Here Are 10 ...
07/09/2025 15:50:29

b-of-a-securities-maintains-underperform-on-rxsight-lowers-price-target-to-9
B of A Securities Maintains Underperform o...
07/09/2025 15:43:04

B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and lowers the price target from $...

dow-jumps-200-points-us-wholesale-inventories-fall-03-in-may
Dow Jumps 200 Points; US Wholesale Invento...
07/09/2025 14:36:55

piper-sandler-maintains-neutral-on-rxsight-lowers-price-target-to-10
Piper Sandler Maintains Neutral on RxSight...
07/09/2025 14:03:39

Piper Sandler analyst Adam Maeder maintains RxSight (NASDAQ:RXST) with a Neutral and lowers the price target from $18 to $10.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION